SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K12G3 - Notification of securities of successor issuers deemed to registered [Section 12]:
SEC Accession No. 0001636050-20-000093
Filing Date
2020-11-13
Accepted
2020-11-13 07:05:24
Documents
21
Period of Report
2020-11-12
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12G3 siox-20201112.htm   iXBRL 8-K12G3 57916
2 EX-3.1 a8-k12g3exhibit31.htm EX-3.1 39638
3 EX-3.2 a8-k12g3exhibit32.htm EX-3.2 165147
4 EX-4.1 siox8k12g3exhibit41.htm EX-4.1 9210
5 EX-4.2 a8-k12g3exhibit42.htm EX-4.2 27953
6 EX-99.1 a8-k12g3exhibit991.htm EX-99.1 50546
12 GRAPHIC siox8k12g3exhibit41001.jpg GRAPHIC 182634
13 GRAPHIC siox8k12g3exhibit41002.jpg GRAPHIC 102776
  Complete submission text file 0001636050-20-000093.txt   1019797

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20201112.xsd EX-101.SCH 2418
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20201112_cal.xml EX-101.CAL 710
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20201112_def.xml EX-101.DEF 17970
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20201112_lab.xml EX-101.LAB 35313
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20201112_pre.xml EX-101.PRE 18923
14 EXTRACTED XBRL INSTANCE DOCUMENT siox-20201112_htm.xml XML 16467
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036 877-746-4891
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 8-K12G3 | Act: 34 | File No.: 000-56226 | Film No.: 201309136
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences